- National Center for Advancing Translational Sciences (NIH): Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies (UH3TR003897) from 09/01/2023 to 08/30/2026
- Department of Defense: Exploring a Novel Therapeutic Strategy to Induce Metabolic Reprogramming for Mitochondrial Diseases (PR190583) from 03/01/2020 to 02/28/2024
- National Center for Advancing Translational Sciences (NIH): Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies (UG3 TR003897) from 07/01/2021 to 08/31/2023
